Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Communication between pathogenic T cells and myeloid cells in neuroinflammatory disease.
Hypogeusia as a symptom of neuromyelitis optica spectrum disorder.
Therapeutic inhibition of the alternative complement pathway attenuates chronic EAE.
A modified superantigen rescues Ly6G(-)CD11b(+)blood monocyte suppressor function and suppresses antigen-specific inflammation in EAE.
Multiple sclerosis: from molecules to treatment.
A "candidate-interactome" aggregate analysis of genome-wide association data in multiple sclerosis.
A Discrete Choice Experiment to Determine Patient Preferences for Injection Devices in Multiple Sclerosis.
Prevalence and Impact of Pain in Adults Aging With a Physical Disability: Comparison to a US General Population Sample.
Fibrinogen: A Circulating Factor in Search for Its Genetic Architecture.
The specific antigen approach in multiple sclerosis: Can it ever be enough?
Reduced Retinal Nerve Fiber Layer Thickness and Macular Volume in Pediatric Multiple Sclerosis.
Acute Disseminated Encephalomyelitis Following 2009 H1N1 Influenza Vaccination.
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.
Treadmill training in multiple sclerosis: can body weight support or robot assistance provide added value? A systematic review.
Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.
Severe Bilateral Heterotopic Ossification in a Patient With Multiple Sclerosis.
Leber's optic neuropathy associated with disseminated white matter disease: a case report and review.
The Retrovirus/Superantigen Hypothesis of Multiple Sclerosis.
Clinical use of brain volumetry.
Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.
Acute lumbosacral transverse myelitis.
Gait and six-minute walk performance in persons with multiple sclerosis.
The role of the parent compound vitamin d with respect to metabolism and function: why clinical dose intervals can affect clinical outcomes.
Anti-idiotypic network induced by T cell vaccination against experimental autoimmune encephalomyelitis.
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
Pages
« first
‹ previous
…
333
334
335
336
337
338
339
340
341
…
next ›
last »